Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Screeners that run automatically... and then email you the results! FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

23Andme Holding CO (ME)

23Andme Holding CO (ME)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,284,635
  • Shares Outstanding, K 449,173
  • Annual Sales, $ 271,890 K
  • Annual Income, $ -217,490 K
  • 60-Month Beta 1.18
  • Price/Sales 4.94
  • Price/Cash Flow N/A
  • Price/Book 1.57
Trade ME with:

Options Overview Details

View History
  • Implied Volatility 82.92% ( -5.08%)
  • Historical Volatility 101.61%
  • IV Percentile 19%
  • IV Rank 36.62%
  • IV High 116.84% on 08/11/22
  • IV Low 63.33% on 10/12/21
  • Put/Call Vol Ratio 0.73
  • Today's Volume 338
  • Volume Avg (30-Day) 964
  • Put/Call OI Ratio 0.31
  • Today's Open Interest 105,658
  • Open Int (30-Day) 108,921

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr N/A
See More
  • Average Estimate N/A
  • Number of Estimates N/A
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.63 +8.75%
on 09/23/22
3.68 -22.28%
on 09/12/22
-0.32 (-10.06%)
since 08/30/22
3-Month
2.46 +16.26%
on 07/01/22
6.31 -54.68%
on 08/11/22
+0.38 (+15.32%)
since 06/30/22
52-Week
2.12 +34.91%
on 06/13/22
13.68 -79.09%
on 11/08/21
-6.20 (-68.43%)
since 09/30/21

Most Recent Stories

More News
2 Ex-SPACs I Wouldn't Touch Right Now

I own both of these companies but wouldn't put any more money into them today.

LTCH : 0.9536 (+6.42%)
ME : 2.86 (-4.35%)
Despite Some Big Losers, These Growth Stocks Are Keeping the Nasdaq Bull Market Going

Investors continue to slowly move away from worries about the economy, inflation, and interest rates, sending growth stocks higher. It's not all good news and positivity, though.

COMP : 2.32 (-0.43%)
$NASX : 10,575.62 (-1.51%)
ENVX : 18.33 (+4.83%)
ME : 2.86 (-4.35%)
TRUP : 59.43 (-2.24%)
SONO : 13.90 (-0.79%)
MQ : 7.12 (+0.56%)
23andMe Reports FY2023 First Quarter Financial Results

First quarter revenue grew 9% to $64.5 millionConsumer revenue grew 17% year over year due to the addition of telehealth revenueOn track to achieve FY2023...

ME : 2.86 (-4.35%)
Why 23andMe Stock Jumped Higher on Monday

Trading volume is surging in the hours leading up to its quarterly financial report.

ME : 2.86 (-4.35%)
23andMe to Report FY2023 First Quarter Financial Results

SOUTH SAN FRANCISCO, Calif., July 25, 2022 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research...

ME : 2.86 (-4.35%)
Should You Scoop Up Shares of 23andMe?

23andMe (ME) saw its shares slump in price after it reported its fourth-quarter earnings results last month. However, given the company's multiple FDA authorizations for over-the-counter genetic health...

A : 121.55 (-0.97%)
CO : 2.99 (+34.58%)
ME : 2.86 (-4.35%)
QGEN : 41.28 (+0.15%)
Why 23andMe Stock Was Lagging the Market Today

The genetics company misses on both the top and bottom lines in its fourth quarter.

ME : 2.86 (-4.35%)
23andMe Reports FY2022 Fourth Quarter and Full Year Financial Results

Achieved FY2022 financial guidanceFourth quarter and full year revenues of $101 million and $272 million representing 14% and 11% increases over prior...

ME : 2.86 (-4.35%)
Quarterhill Appoints John Karnes as CFO

/CNW/ - Quarterhill Inc. ("Quarterhill" or "the Company") (TSX: QTRH) (OTCQX: QTRHF) announces that John Karnes has been appointed Chief Financial Officer...

ME : 2.86 (-4.35%)
THX.LN : 14.600 (-2.67%)
QTRHF : 1.1800 (-8.17%)
QTRH.TO : 1.64 (-1.80%)
23andMe to Report FY2022 Fourth Quarter and Full Year Financial Results

SUNNYVALE, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company,...

ME : 2.86 (-4.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

23andMe Inc. is a consumer genetics and research company. It involved in discovery programs rooted in human genetics across a spectrum of disease areas, including oncology, respiratory and cardiovascular diseases, in addition to other therapeutic areas. 23andMe Inc., formerly known as VG Acquisition...

See More

Key Turning Points

3rd Resistance Point 3.21
2nd Resistance Point 3.13
1st Resistance Point 3.00
Last Price 2.86
1st Support Level 2.79
2nd Support Level 2.71
3rd Support Level 2.58

See More

52-Week High 13.68
Fibonacci 61.8% 9.26
Fibonacci 50% 7.90
Fibonacci 38.2% 6.54
Last Price 2.86
52-Week Low 2.12

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar